Affiliation:
1. Oswaldo Cruz Foundation, Brazil
2. Oswaldo Cruz Foundation, Brazil; Rio de Janeiro Federal University, Brazil
3. Oswaldo Cruz Foundation, Brazil; Productivity scholarship from Scientific and Technology National Council (CNPq), Brazil; Our State Scientist from Carlos Chagas Filho Foundation for the Research Support in Rio de Janeiro State (FAPERJ)
Abstract
We report a case of a 42 year-old female, who came to a leishmaniasis reference center in Rio de Janeiro, Brazil, presenting a cutaneous leishmaniasis lesion in the right forearm. Treatment with low-dose intramuscular meglumine antimoniate (MA) (5 mg Sb5+/kg/day) was initiated, with improvement after 28 days, although with the development of generalized eczema. After 87 days, the lesion worsened. Patient refused treatment with amphotericin B. MA was then infiltrated in the lesion, in two sessions, resulting in local eczema, with bullae formation; however, twenty days after, both the ulcer and eczema receded. Intralesional administration of MA should be used carefully when previous cutaneous hypersensitivity is detected.
Subject
Infectious Diseases,General Medicine
Reference7 articles.
1. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate;Aste N;Br J Dermatol,1998
2. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens;Behin R;Clin Exp Immunol,1977
3. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis;Córdoba S;Allergy,2012
4. Topical treatments for cutaneous warts;Kwok CS;Cochrane Database Syst Rev,2012
5. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil - an area of Leishmania (V.) braziliensis transmission;Oliveira MP;Int J Dermatol,1997
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献